Europa Biosite is pleased to announce the appointment of Sara Fors as Chief Financial Officer (CFO), strengthening the company's leadership team as it continues to expand its presence across the European and US life science and diagnostics markets.
With extensive experience guiding international, high-growth and private equity-backed businesses, Sara brings a wealth of financial and commercial expertise to Europa Biosite. In her new role, she will help shape the company's financial strategy and support the delivery of its long-term growth objectives.
Based in Stockholm, Sara will oversee the Group Finance organisation and play a key role in supporting Europa Biosite's continued growth and development.
As Europa Biosite continues to build a stronger, more integrated life science and diagnostics distribution platform, the company recognises the importance of robust financial leadership in supporting its long-term objectives, strategic investments, and continued expansion.
"We are delighted to welcome Sara to Europa Biosite," said Claudia Berrón, CEO. "Her experience in financial leadership roles within complex, high-growth businesses will be invaluable as we continue to strengthen our organisation and create value for our customers, suppliers, and stakeholders."
Sara's appointment reflects Europa Biosite's ongoing commitment to investing in the people, capabilities, and infrastructure needed to support researchers and life science and diagnostics organisations across Europe and the US.